Yi-Ling Chen Selected Research

Lipopolysaccharides

9/2018	Daily melatonin protects the endothelial lineage and functional integrity against the aging process, oxidative stress, and toxic environment and restores blood flow in critical limb ischemia area in mice.
10/2017	Effective protection against acute respiratory distress syndrome/sepsis injury by combined adipose-derived mesenchymal stem cells and preactivated disaggregated platelets.
1/2017	Melatonin treatment enhances therapeutic effects of exosomes against acute liver ischemia-reperfusion injury.
11/2016	Preactivated and Disaggregated Shape-Changed Platelets Protected Against Acute Respiratory Distress Syndrome Complicated by Sepsis Through Inflammation Suppression.
1/2011	Elephantopus scaber inhibits lipopolysaccharide-induced liver injury by suppression of signaling pathways in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yi-Ling Chen Research Topics

Disease

38	Inflammation (Inflammations) 03/2024 - 01/2011
37	Neoplasms (Cancer) 04/2024 - 08/2003
19	Fibrosis (Cirrhosis) 03/2024 - 01/2014
17	Ischemia 11/2023 - 11/2012
11	Reperfusion Injury 11/2023 - 09/2015
10	Infections 01/2024 - 10/2008
9	Hypoxia (Hypoxemia) 01/2020 - 11/2012
8	COVID-19 10/2023 - 06/2020
8	Neoplasm Metastasis (Metastasis) 09/2023 - 01/2015
8	Sepsis (Septicemia) 10/2017 - 04/2008
7	Shock 04/2019 - 01/2014
6	Lung Injury 03/2024 - 11/2016
6	Breast Neoplasms (Breast Cancer) 01/2023 - 10/2016
6	Pain (Aches) 01/2023 - 09/2014
6	Carcinoma (Carcinomatosis) 01/2023 - 10/2008
6	Infarction (Infarctions) 01/2023 - 08/2015
6	Chronic Renal Insufficiency 12/2022 - 01/2015
6	Stomach Neoplasms (Stomach Cancer) 01/2021 - 10/2011
6	Carcinogenesis 01/2021 - 01/2015
6	Body Weight (Weight, Body) 01/2020 - 07/2006
5	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2023 - 04/2008
5	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 10/2011
5	Adenocarcinoma 01/2020 - 01/2015
4	Cardio-Renal Syndrome 04/2022 - 11/2016
4	Heart Failure 04/2022 - 12/2015
4	Insulin Resistance 06/2018 - 02/2010
3	Diabetic Nephropathies (Diabetic Nephropathy) 06/2023 - 06/2018
3	Myocardial Infarction 01/2023 - 08/2015
3	Atopic Dermatitis (Atopic Eczema) 01/2023 - 12/2017
3	Neuralgia (Stump Neuralgia) 10/2022 - 01/2017
3	Chronic Limb-Threatening Ischemia 01/2022 - 09/2018
3	Brain Infarction 07/2021 - 11/2016
3	Ischemic Stroke 10/2019 - 02/2016
3	Brain Edema (Cerebral Edema) 01/2019 - 02/2016
3	Bronchopulmonary Dysplasia 04/2008 - 07/2007
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023 - 01/2016
2	Lung Neoplasms (Lung Cancer) 09/2023 - 01/2016
2	Cataract (Cataracts) 05/2023 - 03/2011
2	Lymphatic Metastasis 01/2023 - 01/2015
2	Diabetic Neuropathies (Diabetic Neuropathy) 01/2023 - 01/2015
2	Pulmonary Arterial Hypertension 01/2023 - 01/2014

Drug/Important Bio-Agent (IBA)

51	Proteins (Proteins, Gene)FDA Link 11/2023 - 04/2011
27	Biomarkers (Surrogate Marker)IBA 11/2023 - 10/2011
25	Caspase 3 (Caspase-3)IBA 06/2023 - 11/2012
14	MelatoninIBA 01/2020 - 09/2015
13	salicylhydroxamic acid (SHAM)IBA 01/2023 - 08/2015
11	Cytochromes c (Cytochrome c)IBA 01/2023 - 09/2015
10	CytokinesIBA 03/2024 - 08/2004
10	Matrix Metalloproteinases (MMPs)IBA 06/2023 - 09/2015
10	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 08/2004
10	Therapeutic UsesIBA 10/2022 - 08/2004
9	CreatinineIBA 06/2023 - 06/2010
9	Messenger RNA (mRNA)IBA 01/2023 - 01/2014
9	Small Interfering RNA (siRNA)IBA 12/2017 - 01/2009
8	Oxygen (Dioxygen)IBA 07/2021 - 08/2009
7	CollagenIBA 01/2019 - 01/2014
6	Exenatide (Byetta)FDA Link 01/2017 - 11/2015
5	InterleukinsIBA 03/2024 - 12/2014
5	EnzymesIBA 11/2023 - 06/2010
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 12/2015
5	LipidsIBA 01/2023 - 10/2016
5	LipopolysaccharidesIBA 09/2018 - 01/2011
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2024 - 01/2014
4	AntigensIBA 01/2023 - 12/2017
4	Interleukin-6 (Interleukin 6)IBA 07/2021 - 01/2014
4	AntioxidantsIBA 01/2019 - 02/2014
4	Chemokine CCL5IBA 01/2017 - 01/2014
3	Sirtuin 1IBA 12/2023 - 09/2018
3	sacubitril and valsartan sodium hydrate drug combinationIBA 12/2023 - 08/2019
3	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2021
3	AlbuminsIBA 01/2023 - 06/2010
3	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 11/2006
3	Arginine (L-Arginine)FDA Link 11/2022 - 04/2015
3	Peptides (Polypeptides)IBA 11/2020 - 04/2011
3	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2020 - 11/2016
3	Complementary DNA (cDNA)IBA 01/2020 - 01/2015
3	Vitamin K 3 (Menadione)FDA Link 09/2018 - 01/2015
3	Triglycerides (Triacylglycerol)IBA 06/2018 - 02/2010
3	Retinol-Binding Proteins (Retinoid Binding Proteins)IBA 01/2018 - 02/2010
3	DNA VaccinesIBA 12/2017 - 08/2004
3	Indicators and Reagents (Reagents)IBA 01/2017 - 11/2015
3	Phosphotransferases (Kinase)IBA 06/2016 - 11/2012
3	LeptinIBA 01/2015 - 02/2010
2	MicroRNAs (MicroRNA)IBA 03/2024 - 01/2020
2	Transforming Growth Factor beta (TGF-beta)IBA 03/2024 - 01/2020
2	erucylphosphocholineIBA 01/2024 - 01/2021
2	Interleukin-17 (Interleukin 17)IBA 11/2023 - 12/2022
2	empagliflozinIBA 06/2023 - 01/2023
2	Cyclophilins (Cyclophilin)IBA 01/2023 - 01/2020
2	Voltage-Gated Sodium ChannelsIBA 01/2023 - 04/2019

Therapy/Procedure

38	Therapeutics 12/2023 - 01/2009
5	Length of Stay 01/2023 - 04/2008
5	Nephrectomy 12/2022 - 01/2015
4	Ligation 01/2019 - 08/2015
4	Extracorporeal Shockwave Therapy 01/2019 - 01/2014
3	Immunotherapy 04/2024 - 01/2017
3	Intravenous Injections 01/2024 - 01/2016
3	Aftercare (After-Treatment) 10/2022 - 09/2014
2	Adjuvant Chemotherapy 11/2023 - 01/2023
2	Mechanical Ventilators (Ventilator) 01/2023 - 08/2009